Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death

Carcinogenesis

Volumn 18, Issue 9, 1997, Pages 1799-1808

  Srivastava, Pramod ^a   Russo, Jose ^a   Russo, Irma H ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; DIMETHYLBENZ[A]ANTHRACENE; PROTEIN BCL 2; PROTEIN P53; RNA; TRANSFORMING GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; RAT; TUMOR SUPPRESSOR GENE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADENOCARCINOMA; ANIMALS; APOPTOSIS; CHORIONIC GONADOTROPIN; FEMALE; GENES, TUMOR SUPPRESSOR; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0031410992     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.9.1799     Document Type: Article

References (74)

1. Huggins, C., Grand, L.C. and Brillantes, F.P. (1959) Critical significance of breast structure in the induction of mammary cancer in the rat. Proc. Natl Acad. Sci. USA, 45, 1294-1300.
2. Dao, T.L. and Sunderland, H. (1959) Mammary carcinogenesis by 3-methylcholanthrene. I. Hormonal aspects in tumor induction and growth. J. Natl Cancer Inst., 23, 567-586.
3. Huggins, C.B. (1979) Acceleration and extinction of mammary cancer. In Experimental Leukemia and Mammary Cancer. The University of Chicago Press, Ltd, London, pp. 99-112.
4. Russo, J., Tay, L.K. and Russo, I.H. (1982) Differentiation of the mammary gland and susceptibility to carcinogenesis. A review. Breast Cancer Res. Treat., 2, 5-73.
5. Welsch, C.W. (1985) Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res., 45, 3415-3443.
6. Nandi, S., Guzman, R.C. and Yang, J. (1995) Hormones and mammary carcinogenesis in mice, rats, and humans. A unifying hypothesis. Proc. Natl Acad. Sci. USA, 92, 3650-3657.
7. Russo, I.H. and Russo, J. (1996) Mammary gland neoplasia in long term rodent studies. Environ. Health Perspect., 104, 938-967.
8. Russo, J. and Russo, I.H. (1980) Influence of differentiation and cell kinetics on the susceptibility of the mammary gland to carcinogenesis. Cancer Res., 40, 2677-2687.
9. Russo, I.H. and Russo, J. (1986) From pathogenesis to hormone prevention of mammary carcinogenesis. Cancer Surveys, 5, 649-670.
10. Grubbs, C.J., Juliana, M.M. Hill, D.L. and Whitaker, L.M. (1986) Suppression by pregnancy of chemically induced preneoplastic cells of the rat mammary gland. Anticaner Res., 6, 1395-1400.
11. Sinha, D.K. and Pazik, J.E. (1981) Tumorigenesis of mammary gland by 7,12-dimethylbenz[a]anthracene during pregnancy: relationship with DNA synthesis. Intl J. Cancer, 27, 807-810.
12. Russo, I.H., Koszalka, M. and Russo, J. (1990) Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br. J. Cancer, 62, 243-247.
13. Russo, I.H., Koszalka, M. and Russo, J. (1990) Human chorionic gonadotropin and rat mammary cancer prevention. J. Natl Cancer Inst., 82, 1286-1289.
14. Russo, I.H. and Russo, J. (1993) Chorionic gonadotropin, a tumoristatic and preventive agent in breast cancer. In B.A.Teicher (ed.) Drug Resistance in Oncology. Marcel Dekker, Inc., New York, pp. 537-560.
15. Russo, I.H., Koszalka, M. and Russo, J. (1990) Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Carcinogenesis, 11, 1849-1855.
16. Russo, J. and Russo, I.H. (1994) Toward a physiological approach to breast cancer prevention. Cancer Epidemiol. Biomark. Prevent., 3, 353-364.
17. Simpson, E.R. and MacDonald, P.C. (1981) Endocrine physiology of the placenta. Annu. Rev. Physiol., 43, 163-188.
18. Lockshin, R.A. and Zakeri, Z. (1991) Programmed cell death and apoptosis. In Tomei, L.D. and Cope, F.O. (eds) Apoptosis: The Molecular Bases of Cell Death. Current Communications in Cell and Molecular Biology; 3. Cold Spring Harbor Laboratory Press, Plainview, NY, pp. 47-60.
19. Lockshin, R.A. and Zakeri, Z. (1996) The biology of cell death and its relationship to aging. In Holbrook, N.J., Martin, G.R and Lockshin, R.A. (eds) Cellular Aging and Cell Death. Wiley-Liss, Inc., New York, pp. 167-180.
20. Bissonnette, R.P., Echeverri, F., Mahboubi, A. and Green, D.R. (1992) Apoptotic cell death induced by c-myc is inhibited by blc2. Nature, 359, 552-554.
21. Kimura, S., Maekawa, T., Hirakawa, K., Murakami, A. and Abe, T. (1995) Alterations of c-myc expression by antisensenucleotides enhance the induction of apoptosis in HL60 cells. Cancer Res., 55, 1379-1384.
22. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z. and Hancock, C. (1993) Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69, 119-128.
23. Marx, J. (1993) Cell death studies yield cancer clues. Science, 259, 760-761.
24. Hoffman, B. and Lieberman, D.A. (1994). Molecular controls of apoptosis: differentiation/growth arrest primary response genes, protoncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene, 9, 1807-1812.
25. Wong, P., Pineault, J., Taillefer, D., Leger, J., Wang, C. and Tenniswood, M. (1993) Genomic organization and expression of the rat TRPM2 (Clusterin) gene, a gene implicated in apoptosis. J. Biol. Chem., 7, 5021-5031.
26. Wong, P., Taillefer, D., Lakins, J., Chader, G. and Tenniswood, M. (1994) Molecular characterization of human TRPM-2/Clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneratin. Eur. J. Biochem., 221, 917-925.
27. Munday, N.A., Vaillancourt, J.P., Ali, A., Casano, F.J., Miller, D.K., Molineaux, S.M., Yamin, T., Yu, V.L. and Nicholson, D.W. (1995) Molecular cloning and pro-apoptotic activity of ICE-reIIII, members of the ICE/ CED-3 family of cysteine-proteases. J. Biol. Chem., 270, 15870-15876.
28. Fernandes-Alnemri, T., Takashi, A., Armstrong, R. et al. (1995) Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res., 55, 6045-6052.
29. Fernandes-Alnemri, T., Litwack, G. and Alnemri, E.S. (1995) Mch2, a new member of the apoptotic Ced-3/ICE cysteine protease gene family. Cancer Res., 55, 2737-2742.
30. Kamens, J., Paskind, M., Hugunin, M. et al. (1995) Identification and characterization of ICH-2, a novel member of the interleukin-1β-converting enzyme family of cysteine proteases. J. Biol. Chem., 270, 15250-15256.
31. Tewari, M., Quan, L.T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D.R., Poirier, G.G., Salvesen, G.S. and Dixit, V.M. (1995). Yama/CPP32 β, a mammalian homolog of CED-3, is a Crm A-inhitable protease that cleaves the death substrate poly(ADP-Ribose) polymerase. Cell, 81, 801-809.
32. Yuan, J., Shaham, S., Leduox, S., Ellis, H.M. and Horvitz, H.R. (1993) The C.elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell, 75, 641-652.
33. Gagliardini, V., Fernandez, P.A., Lee, R.K.K., Drexler, H.C.A., Rotello, R.J., Fishman, M.C. and Yuan, J. (1994) Prevention of vertebrate neuronal death by CrmA gene. Science, 263, 826-828.
34. Taetle, R., Payne, C., Santos, B.D., Russell, M. and Segarini, P. (1993) Effects of transforming growth factor β1 on growth and apoptosis of human acute myelogenous leukemia cells. Cancer Res., 53, 3386-3393.
35. Armstrong, D.K., Issacs, J.T., Ottaviano, Y.L. and Davidson, N.E. (1992) Programmed cell death in an estrogen-independent human breast cancer cell line. MDA-MB-468. Cancer Res., 52, 3418-3424.
36. Korsmeyer, S.J. (1995) Regulators of cell death. Trends Genetics, 11, 101-105.
37. White, E. (1996) Life, death, and pursuit of apoptosis. Genes Develop., 10, 1-15.
38. Boise, L.H., Gonzalez-Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G. and Thompson, C.B. (1993) Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608.
39. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
40. Sakamuro, D., Eviner, V., Elliott, K.J., Showe, L., Whitw, E. and Prendergast, G.C. (1995) c-myc induces apoptosis in epithelial cells by both p53 dependent and p53 independent mechanisms. Oncogene, 11, 2411-2418.
41. Liebermann, D.A., Hoffman, B. and Steinman, R.A. (1995) Molecular control of growth arrest and apoptosis: p53 dependent and independent pathways. Oncogene, 11, 199-210.
42. Ronen, D., Schwartz, D., Teitz,Y., Goldfinger, N. and Rotter, V. (1996) Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Different., 7, 21-30.
43. Li, M., Hu, J., Hennighausen, L. and Furth, P.A. (1996) Apoptosis and remodelling of mammary gland tissue during involution proceeds through p53 independent pathways. Cell Growth Different., 7, 13-20.
44. Li, M., Hu, J., Hennighausen, L. and Furth, P.A. (1996) Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53 independent apoptosis is followed by impaired milk protein production in surviving cells. Cell Growth Different., 7, 3-11.
45. Evan, G.I. and Littlewood, T.D. (1993) The role of c-myc in cell growth. Current Opinions Genetics Develop., 3, 44-49.
46. Russo, J., Gusterson, B.A., Rogers, A.E., Russo, I.H., Wellings, S.R. and van Zwieten, M.J. (1990) Comparative study of human and rat mammary tumorigenesis. Lab. Invest., 62, 1-32.
47. Russo, J., Russo, I.H., Rogers, A.E., van Zwieten, M.J. and Gusterson, B. (1990) Tumors of the mammary gland. In Turusov, V. and Mohr, H. (eds) Pathology of Tumors of Laboratory Animals, Vol. 1. pp. 47-78.
48. Chomczynski, P. and Sacchi, N. (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
49. Tay, L.K. and Russo, J. (1981) Formation and removal of 7,12-dimethylbenz[a]anthracene-nucleic acid adducts in rat mammary epithelial cells with different susceptibility to carcinogenesis. Carcinogenesis, 2, 1327-1333.
50. Tay, L.K. and Russo, J. (1985) Effect of human chorionic gonadotropin on 7,12-dimethylbenz[a]anthracene-induced DNA binding and repair synthesis by rat mammary epithelial cells. Chem.-Biol. Interactions, 55, 13-21.
51. Russo, I.H. and Russo, J. (1994) Role of hCG and inhibin in breast cancer. Int. J. Oncol., 4, 297-306.
52. Russo, I.H., Ao, X., Tahin, S. and Russo, J. (1996) Chorionic gonadotropin inhibits mammary tumor progression by inducing differentiation of the initiated cells. Proc. Am. Assoc. Cancer Res., 37, 1066.
53. Srivastava, P., Russo, J., Estrada, S. and Russo, I.H. (1996) p53 and cyclins A and D regulate the inhibition of tumor progression induced by chorionic gonadotropin. Proc. Am. Assoc. Cancer Res., 37, 2.
54. Srivastava, P., Russo, J. and Russo, I.H. (1996) Chorionic gonadotropin induces programmed cell death in the rat mammary gland. Proc. Am. Assoc. Cancer Res., 37, 98.
55. Russo, I.H., Srivastava, P., Mgbonyebi, P. and Russo, J. (1997) Activation of programmed cell death by human chorionic gonadotrophin in breast cancer therapy. Acta Haematologica, 98, 16.
56. Lee, C.Y. and Ryan, R.J. (1972) Luteinizing hormone receptors: specific binding of human luteinizing hormone to homogenates of luteinized rat ovaries. Proc. Natl Acad. Sci. USA, 69, 3520-3523.
57. Ronai, Z., Tillotson, J.K., Trganos, F., Darzynkiewixz, Z., Conaway, C.C., Upadhyaya, P. and El-Bayoumy, K. (1995) Effects of organic and inorganic selenium compounds on rat mammary tumor cells. Int. J. Cancer, 63, 428-434.
58. Buscail, L., Esteve, J., Saint-Laurent, N., Bertrand, V., Reisine, T., O'Carroll, A., Bell, G.I., Schally, A.V., Vaysse, N. and Susini, C. (1995) Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 analogue SSTR5 through different mechanisms. Proc. Natl Acad. Sci. USA, 92, 1580-1584.
59. Yuan, J. and Horvitz, H.R. (1990) The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death. Dev. Biol., 138, 33-41.
60. Kuida, K., Lippke, J.A., Ku, G., Harding, M.W., Livingston, D.J., Su, M.S. and Flavell, R.A. (1995) Altered cytokine export and apoptosis in mice dehcient in interleukin-1β converting enzyme. Science, 267, 2000-2005.
61. Enari, M., Hug, H. and Nagata, S. (1995) Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature, 375, 78-81.
62. Buttyan, R., Olsson, C.A., Pintar, J., Chang, C., Bandyk, M., Ng, P. and Sawczuk, I.S. (1989) Induction of the TRPM2 gene in cells undergoing programmed cell death. Mol. Cell Biol., 9, 3473-3481.
63. Kyprianou, N., English, H.F., Davidson, N.E. and Isaacs, J.T. (1991) Programmed cell death during regression of MCF-7 human breast cancer following estrogen ablation. Cancer Res., 51, 162-166.
64. Kyprianou, N., English, H.F. and Isaacs, J.T. (1990) Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res., 50, 3748-3753.
65. Mgbonyebi, O.P., Tahin, Q., Russo, J. and Russo, I.H. (1996) Serum levels of chorionic gonadotropin in treated female rats during the progression of DMBA-induced tumorigenesis. Proc. Am. Assoc. Cancer Res., 37, 1564.
66. Tahin, Q., Mgbonyebi, O.P., Russo, J. and Russo, I.H. (1996) Influence of hormonal changes induced by the placental hormone chorionic gonadotropin on the progression of mammary tumorigenesis. Proc. Am. Assoc. Cancer Res., 37, 1622.
67. Tao, Y.-X., Lei, Z.M. and Rao, Ch.V. (1997) The presence of luteinizing hormone/human chorionic gonadotrophin receptors in lactating rat mammary glands. Life Sciences, 60, 1297-1303.
68. Williams, G.T. and Smith, C.A. (1993) Molecular regulation of apoptosis: Genetic control on cell death. Cell, 74, 777-779.
69. Hermeking, H. and Eick, D. (1994) Mediation of c-myc-induced apoptosis by p53. Science, 265, 2091-2093.
70. waf1/cip1. Genes Dev., 8, 2817-2830.
71. Reed, J.C. (1995) Bcl-2. Prevention of apoptosis as a mechanism of drug resistance. Hematol. Oncol. North Am., 9, 451-474.
72. Reed, J.C. (1995) Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol., 7, 541-546.
73. Krajewski, S., Blomvquist, C., Franssila, K., Krajewska, M., Wasenius, V-M., Niskanen, E. and Reed, J.C. (1995) Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination therapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res., 55, 4471-4478.
74. Krajewski, S., Krajewska, M. and Reed, J.C. (1996) Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res., 56, 2849-2855.